Apyrase protects against allergic airway inflammation by decreasing the chemotactic migration of dendritic cells in mice

  • Authors:
    • Ping Li
    • Jie Cao
    • Yifei Chen
    • Wei Wang
    • Jiong Yang
  • View Affiliations

  • Published online on: May 6, 2014     https://doi.org/10.3892/ijmm.2014.1771
  • Pages: 269-275
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Recent studies have demonstrated that extracellular adenosine 5'-triphosphate (eATP) is involved in allergic airway inflammation by activating purinergic receptors. eATP can be hydrolyzed by ectonucleotidases, such as CD39. In this study, we investigated the expression and distribution of CD39 in the lungs of mice, as well as the effects of apyrase on airway inflammation and the chemotactic migration of dendritic cells (DCs). A mouse model of asthma was developed with chicken ovalbumin (OVA)/aluminum hydroxide using female C57BL/6 mice. Apyrase was administered to OVA-sensitized mice prior to each challenge by intraperitoneal injection. The distribution of CD39 was detected by immunofluorescence. The mRNA and protein expression of CD39 was determined by quantitative PCR and western blot analysis, respectively. The levels of Th2 cytokines in the bronchoalveolar lavage fluid (BALF) were measured by enzyme-linked immunosorbent assay (ELISA). The effect of apyrase on the chemotactic migration of DCs towards ATP was explored by migration assay in vitro. In the lungs, CD39 was primarily located in the cytoplasm and cytomembrane of bronchial epithelial cells and CD39 expression was reduced in mice with allergic asthma. Treatment with apyrase markedly attenuated OVA-induced airway inflammation, including peribronchial eosinophilic inflammation and reduced the number of inflammatory cells, as well as the levels of cytokines in BALF. Furthermore, apyrase also markedly reduced the expression of GATA binding protein 3 (GATA3) and decreased the chemotactic migration of DCs towards ATP.Our data demonstrate that a reduction in CD39 expression may be associated with the development of allergic airway inflammation and that apyrase alleviates airway inflammation by decreasing the chemotactic migration of DCs towards eATP. Therefore, targeting at eATP or ectonucleotidases may provide a novel therapeutic approach for allergic asthma.
View Figures
View References

Related Articles

Journal Cover

July 2014
Volume 34 Issue 1

Print ISSN: 1107-3756
Online ISSN:1791-244X

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
APA
Li, P., Cao, J., Chen, Y., Wang, W., & Yang, J. (2014). Apyrase protects against allergic airway inflammation by decreasing the chemotactic migration of dendritic cells in mice. International Journal of Molecular Medicine, 34, 269-275. https://doi.org/10.3892/ijmm.2014.1771
MLA
Li, P., Cao, J., Chen, Y., Wang, W., Yang, J."Apyrase protects against allergic airway inflammation by decreasing the chemotactic migration of dendritic cells in mice". International Journal of Molecular Medicine 34.1 (2014): 269-275.
Chicago
Li, P., Cao, J., Chen, Y., Wang, W., Yang, J."Apyrase protects against allergic airway inflammation by decreasing the chemotactic migration of dendritic cells in mice". International Journal of Molecular Medicine 34, no. 1 (2014): 269-275. https://doi.org/10.3892/ijmm.2014.1771